COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...